Motus GI Holdings, Inc. (NASDAQ:MOTS) Expected to Earn Q3 2022 Earnings of ($0.12) Per Share

Motus GI Holdings, Inc. (NASDAQ:MOTS – Get Rating) – Oppenheimer issued their Q3 2022 earnings per share (EPS) estimates for Motus GI in a research note issued to investors on Monday, April 25th. Oppenheimer analyst S. Lichtman expects that the company will earn ($0.12) per share for the quarter. Oppenheimer also issued estimates for Motus GI’s FY2022 earnings at ($0.47) EPS and FY2023 earnings at ($0.36) EPS.

Motus GI (NASDAQ:MOTS – Get Rating) last posted its earnings results on Tuesday, March 29th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.01. Motus GI had a negative net margin of 4,867.77% and a negative return on equity of 83.71%. During the same period in the previous year, the business posted ($0.12) earnings per share.

Several other research analysts have also recently commented on the stock. Colliers Securities restated a “buy” rating on shares of Motus GI in a research report on Tuesday, March 22nd. Alliance Global Partners dropped their price objective on shares of Motus GI from $1.75 to $1.40 in a research note on Wednesday, January 26th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $1.48.

NASDAQ MOTS opened at $0.26 on Thursday. Motus GI has a 52 week low of $0.26 and a 52 week high of $1.62. The company has a current ratio of 8.26, a quick ratio of 8.09 and a debt-to-equity ratio of 1.18. The stock has a market cap of $14.53 million, a price-to-earnings ratio of -0.48 and a beta of 2.40. The company has a 50-day moving average price of $0.34 and a two-hundred day moving average price of $0.45.

Several institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC increased its position in shares of Motus GI by 654.5% during the 4th quarter. Virtu Financial LLC now owns 346,639 shares of the company’s stock worth $162,000 after purchasing an additional 300,696 shares in the last quarter. Citadel Advisors LLC increased its position in shares of Motus GI by 541.2% during the 4th quarter. Citadel Advisors LLC now owns 178,982 shares of the company’s stock worth $84,000 after purchasing an additional 151,068 shares in the last quarter. LPL Financial LLC acquired a new stake in shares of Motus GI during the 4th quarter worth about $25,000. Millennium Management LLC increased its position in shares of Motus GI by 20.4% during the 3rd quarter. Millennium Management LLC now owns 118,652 shares of the company’s stock worth $82,000 after purchasing an additional 20,110 shares in the last quarter. Finally, BlackRock Inc. increased its position in shares of Motus GI by 13.5% during the 3rd quarter. BlackRock Inc. now owns 202,808 shares of the company’s stock worth $139,000 after purchasing an additional 24,100 shares in the last quarter. Institutional investors and hedge funds own 13.36% of the company’s stock.

About Motus GI (Get Rating)

Motus GI Holdings, Inc, a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Featured Articles